David S. Wishart

Adamo Young, Fei Wang, David S Wishart et al.

Compound identification from tandem mass spectrometry (MS/MS) data is a critical step in the analysis of complex mixtures. Typical solutions for the MS/MS spectrum to compound (MS2C) problem involve comparing the unknown spectrum against a library of known spectrum-molecule pairs, an approach that is limited by incomplete library coverage. Compound to MS/MS spectrum (C2MS) models can improve retrieval rates by augmenting real libraries with predicted MS/MS spectra. Unfortunately, many existing C2MS models suffer from problems with mass accuracy, generalization, or interpretability. We develop a new probabilistic method for C2MS prediction, FraGNNet, that can efficiently and accurately simulate MS/MS spectra with high mass accuracy. Our approach formulates the C2MS problem as learning a distribution over molecule fragments. FraGNNet achieves state-of-the-art performance in terms of prediction error and surpasses existing C2MS models as a tool for retrieval-based MS2C.

Siamak Ravanbakhsh, Philip Liu, Trent Bjorndahl et al.

Many diseases cause significant changes to the concentrations of small molecules (aka metabolites) that appear in a person's biofluids, which means such diseases can often be readily detected from a person's "metabolic profile". This information can be extracted from a biofluid's NMR spectrum. Today, this is often done manually by trained human experts, which means this process is relatively slow, expensive and error-prone. This paper presents a tool, Bayesil, that can quickly, accurately and autonomously produce a complex biofluid's (e.g., serum or CSF) metabolic profile from a 1D1H NMR spectrum. This requires first performing several spectral processing steps then matching the resulting spectrum against a reference compound library, which contains the "signatures" of each relevant metabolite. Many of these steps are novel algorithms and our matching step views spectral matching as an inference problem within a probabilistic graphical model that rapidly approximates the most probable metabolic profile. Our extensive studies on a diverse set of complex mixtures, show that Bayesil can autonomously find the concentration of all NMR-detectable metabolites accurately (~90% correct identification and ~10% quantification error), in <5minutes on a single CPU. These results demonstrate that Bayesil is the first fully-automatic publicly-accessible system that provides quantitative NMR spectral profiling effectively -- with an accuracy that meets or exceeds the performance of trained experts. We anticipate this tool will usher in high-throughput metabolomics and enable a wealth of new applications of NMR in clinical settings. Available at http://www.bayesil.ca.